Lithuania

 

Interview: Dimitris Moulavasilis, CEO, Diaverum 

Will international dialysis group Diaverum IPO or sell? We catch up with its new CEO, the former boss of international imaging group Affidea. Rarely have we met such an enthusiastic leader. That may be just as well. Many wonder whether Diaverum, which has been owned by private equity house Bridgepoint since 2007, can ever be sexed up enough to attract a top price. If anyone can achieve this, it is Moulavasilis. 

Senior Group looks to Baltics for expansion

France-based assisted living operator Senior Group is looking for a Baltics breakthrough after initial ambitious attempts stalled. We speak to CEO Nicolai Kobliakov as the company looks for investors. 

Interview: Giuseppe Recchi, CEO, Affidea

Healthcare Europa speaks to Giuseppe Recchi, CEO of pan-European advanced diagnostic imaging specialist Affidea, to find out about the company’s foray into outpatient care, the state of AI, and plans for the future.

Interview: Giuseppe Recchi, CEO and Rowland Illing, CMO, Affidea

In a wide-ranging interview, we look at Affidea’s strategy and view of the market covering everything from partnerships with AI outfits, elite hospitals and payors through to the growth of private pay and the opportunities to manage entire health systems. How will the imaging services and radiotherapy group with HBI estimated sales of around €370m in 2017 grow and build over the next five years?

Interview: Dr Rajgopal Thirumalai, Vice President, Global Medical & Occupational Health, Unilever

Unilever runs a global health and prevention programme in over 90 countries for its 169,000  employees. How? What does Dr Thirumalai (known as Dr Raj) think of the private healthcare services sector? And what changes does he expect in the future? And what does he expect from digital health and AI? Dr Raj is also a non-executive independent director of Apollo Hospitals Enterprise and a speaker at HBI 2018 on April 10-11 in London.

Interview: Dr Rajgopal Thirumalai, Vice President, Global Medical & Occupational Health, Unilever

Unilever runs a global health and prevention programme in over 90 countries for its 169,000  employees. How? What does Dr Thirumalai (known as Dr Raj) think of the private healthcare services sector? And what changes does he expect in the future? And what does he expect from digital health and AI? Dr Raj is also a non-executive independent director of Apollo Hospitals Enterprise and a speaker at HBI 2018 on April 10-11 in London.

Interview: Attila Vegh, CEO, Penta Hospitals Group

By 2025 Penta Hospitals Group (PHG) owned by private equity house Penta Investments, plans to more than triple sales to over €1bn. But growth could be even faster, says its new CEO, Attila Vegh, a former boss of three large English NHS hospital trusts. The real ambition of the group, a merger of Svet Zdravia in Slovakia, the Polish chain EMC and Penta’s hospitals in Czech Republic, is even greater than the sales forecasts suggest. Much of the growth he says will come from working with the public sector. Vegh says that Penta wants to be “a disrupter, a company which introduces best practice and innovation,” thus persuading public payors to rethink their attitude to the private sector. So how do you do that in a region which is becoming increasingly statist and hostile to international capitalism?

Find Us